Demand for Autologous Cell Therapy Market Sluggish Growth Rate Foreseen by 2019 - 2027

According to Transparency Market Research's latest report on the global autologous cell therapy market for the historical period 2017-2018 and forecast period 2019-2027, Rise in prevalence of autoimmune disorders, cancer, blood related disorders, are projected to drive the global autologous cell therapy market during the forecast period

Research Report: https://www.transparencymarketresearch.com/autologus-cell-therapy-market.html

According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is anticipated to expand at a CAGR of 18.1% from 2019 to 2027.

Strong Product Pipeline and Increasing Government Support Boost Market Growth

Major manufacturers are focusing on research and development activity for new autologous cell therapy products. Currently TESSA Therapeutics has innovative autologous cell therapy product (TT12) in pipeline i.e. Phase 1 for treatment of HPV-Associated Cancers. Strong product pipeline is helps to drive the growth of this market.
Increasing government support and funding is likely to drive the growth of this market during forecasted period. National Institute of Health (NIH) had spent around US$ 2 Bn for stem cells research in the U.S. in 2019.

Get a Sample https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715

Government regulations against unethical harvesting of stem cells and lack of reimbursement in emerging countries to hamper market

Reproductive cloning is banned in U.S. European nations such as Germany, Austria, Portugal and Italy and some Asian nations such as China, South Korea and Israel. However, therapeutic cloning is permitted. The restrictions on research activities had hampered the growth of stem cells and thereby restricting the demand for autologous cell therapy products.

Reimbursements are provided by various governments and private insurance agencies to meet the needs of several patient undergo cell therapy (autologous) treatment. However, lack of reimbursement policies in various less developed and emerging economies for treatment with the help of cell therapy and high cost of treatment restrain the market

Ask for a custom report https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=715

Global Autologous cell therapy Market: Competitive Landscape

This report profiles major players in the global autologous cell therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global autologous cell therapy market is highly fragmented, with the presence of a number of international as well as regional players

Leading players operating in the global autologous cell therapy market are

Pharmicell Co., Inc.
Castle Creek Biosciences, Inc.
Vericel Corporation
Lineage Cell Therapeutics, Inc.
BrainStorm Cell Therapeutics
Caladrius Biosciences, Inc.
Opexa Therapeutics, Inc.
Regeneus Ltd.
Takeda Pharmaceutical Company Limited.
Sangamo Therapeutics
U.S. Stem Cell, Inc.

Report Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=715

Global Autologous cell therapy Market: Key Developments

Key players in the global autologous cell therapy market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global autologous cell therapy market. A few expansion strategies adopted by players operating in the global autologous cell therapy market are:

In October 2019, American Gene Technologies (AGT) submitted Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for AGT103-T in the treatment of HIV patients.

In August 2018, KOLIGO THERAPEUTICS, INC. launched KYSLECEL, which is autologous cell therapy product for treatment of chronic or acute recurrent pancreatitis.

About Transparency Market Research

Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research firm that offers market analysis reports and business consulting. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit our YouTube channel - 

https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact Us:

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: 1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Blog: https://tmrblog.com

Email: sales@transparencymarketresearch.com

This release was published on openPR.